» Articles » PMID: 29609879

Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014

Overview
Journal Clin Ther
Specialty Pharmacology
Date 2018 Apr 4
PMID 29609879
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Chronic obstructive pulmonary disease (COPD) is a leading and costly cause of readmissions to the hospital, with one of the highest rates reported in Florida. From 2009 to 2014, strategies such as readmission reduction programs, as well as updated guidelines for COPD management, were instituted to reduce readmission rates for patients with COPD. Thus, the question has been raised whether COPD-related 30-day hospital readmission rates in Florida have decreased and whether COPD-related readmission costs during this period have changed. In addition, we examined trends in length of stay, hospital charges, and in-hospital mortality associated with COPD, as well as identified patient-level risk factors associated with 30-day readmissions.

Methods: A retrospective analysis of adult patients (≥18 years of age) with COPD was conducted by using the Healthcare Cost and Utilization Project Florida State Inpatient Database, 2009 to 2014. Weighted least squares regression was used to assess trends in the COPD readmission rate on a yearly basis, as well as other outcomes of interest. A multivariable logistic regression was used to identify patient characteristics that were associated with 30-day COPD readmissions.

Findings: Overall, 268,084 adults were identified as having COPD. Between 2009 and 2014, more than half of patients aged 65-84 years, most were white, 55% were female, and 73% had Medicare. The unadjusted rate for COPD-related 30-day readmissions did not change (8.04% to 7.85%; P = 0.434). However, the mean total charge for 30-day COPD-related readmissions was significantly higher in 2014 ($40,611) compared with that in 2009 ($36,714) (P = 0.011). The overall unadjusted in-hospital mortality of COPD-related hospitalizations significantly decreased from 1.83% in 2009 to 1.34% in 2014 (P < 0.001). In a multivariable logistic regression model, patients with COPD were 2% less likely to be readmitted to the hospital for each additional year (odds ratio [OR], 0.98 [95% confidence interval (CI), 0.97-0.99]). Factors associated with significantly higher odds of COPD-related readmission were: older age (45 ≤ age ≤ 64 years; OR, 1.91 [95% CI, 1.70-2.14]), being male (OR, 1.14 [95% CI, 1.10-1.17]), and being a Medicaid beneficiary (OR, 1.28 [95% CI, 1.21-1.35]).

Implications: Although the adjusted odds of COPD readmissions slightly decreased, as did the length of stay and all-cause in-patient mortality, the financial burden increased substantially. Future strategies to further reduce readmissions of patients with COPD and curb financial burden in Florida are needed.

Citing Articles

Reducing Hospital Readmissions in Chronic Obstructive Pulmonary Disease Patients: Current Treatments and Preventive Strategies.

Di Chiara C, Sartori G, Fantin A, Castaldo N, Crisafulli E Medicina (Kaunas). 2025; 61(1).

PMID: 39859079 PMC: 11766895. DOI: 10.3390/medicina61010097.


Improving Patient-Centric COPD Management.

Yawn B Fed Pract. 2025; 41(Suppl 6):S35-S40.

PMID: 39839063 PMC: 11745468. DOI: 10.12788/fp.0534.


Nursing diagnoses and hospital readmission of patients with respiratory diseases: Findings from a case-control study.

Suarez-Gonzalez P, Suarez-Elosegui A, Arias-Fernandez L, Perez-Regueiro I, Jimeno-Demuth F, Lana A Nurs Open. 2024; 11(5):e2182.

PMID: 38783599 PMC: 11116758. DOI: 10.1002/nop2.2182.


[Epidemiology and hospitalization costs analysis of female inpatients with acute exacerbation of chronic obstructive pulmonary disease in Beijing from 2013 to 2020].

Wang Z, Mo J, Zhang M, Liao J Beijing Da Xue Xue Bao Yi Xue Ban. 2023; 55(6):1074-1081.

PMID: 38101792 PMC: 10723980.


Patient and social factors related to nebulizer use in COPD patients at the transition of care: a qualitative study.

Foster A, Stoll J, Daly C, Clark C, Sethi S, Jacobs D BMC Pulm Med. 2023; 23(1):358.

PMID: 37740178 PMC: 10517547. DOI: 10.1186/s12890-023-02651-w.